Expert Opinion on Biological Therapy, Volume 20, Issue 2 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Biological Therapy, Volume 20, Issue 2 (2020)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Volume 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Rationale, discovery and clinical development of NEO-201
Philip M. Arlen & Maria Pia Morelli
Pages: 105-108
Published online: 24 Dec 2019
First Page PreviewforRationale, discovery and clinical development of NEO-201 | Full Text | References | PDF (660.8 KB) | EPUB
  • 2114 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Drug Evaluation

Article
Nivolumab for the treatment of unresectable pleural mesothelioma
Katsuyuki Hotta, Nobukazu Fujimoto, Toshiyuki Kozuki, Keisuke Aoe & Katsuyuki Kiura
Pages: 109-114
Published online: 16 Dec 2019
AbstractforNivolumab for the treatment of unresectable pleural mesothelioma | Full Text | References | PDF (554.9 KB) | EPUB | Supplemental
  • 434 Views
  • 10 CrossRef citations
  • 0Altmetric

Review

Review
Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Mansour Alfayez, Marina Konopleva & Naveen Pemmaraju
Pages: 115-123
Published online: 17 Dec 2019
AbstractforRole of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN) | Full Text | References | PDF (1.2 MB) | EPUB
  • 375 Views
  • 8 CrossRef citations
  • 0Altmetric
Review
Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease
Airan Liu, Xiwen Zhang, Hongli He, Li Zhou, Yoshifumi Naito, Shinji Sugita & Jae-Woo Lee
Pages: 125-140
Published online: 18 Nov 2019
AbstractforTherapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease | Full Text | References | PDF (1.3 MB) | EPUB
  • 940 Views
  • 53 CrossRef citations
  • 0Altmetric
Review
Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy
Florent Amatore, Laurent Gorvel & Daniel Olive
Pages: 141-150
Published online: 28 Nov 2019
AbstractforRole of Inducible Co-Stimulator (ICOS) in cancer immunotherapy | Full Text | References | PDF (903.3 KB) | EPUB
  • 1445 Views
  • 51 CrossRef citations
  • 0Altmetric
Review
Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective
Patrick B. Allen, Stefanos Bonovas, Silvio Danese & Laurent Peyrin-Biroulet
Pages: 151-161
Published online: 20 Jan 2020
AbstractforEvolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective | Full Text | References | PDF (1.1 MB) | EPUB
  • 541 Views
  • 5 CrossRef citations
  • 0Altmetric
Review
Antibody prodrugs for cancer
W. Michael Kavanaugh
Pages: 163-171
Published online: 09 Dec 2019
AbstractforAntibody prodrugs for cancer | Full Text | References | PDF (919.3 KB) | EPUB
  • 995 Views
  • 30 CrossRef citations
  • 0Altmetric

Original Research

Article
In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis
Marco Galluzzo, Simone D’Adamio, Dionisio Silvaggio, Paolo Lombardo, Luca Bianchi & Marina Talamonti
Pages: 173-182
Published online: 27 Dec 2019
AbstractforIn which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis | Full Text | References | PDF (1.5 MB) | EPUB
  • 4566 Views
  • 27 CrossRef citations
  • 0Altmetric
Open Access
Article
Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry
Jan Tužil, Tomáš Mlčoch, Jitka Jirčíková, Jakub Závada, Lucie Nekvindová, Michal Svoboda, Michal Uher, Zlatuše Křístková, Jiří Vencovský, Karel Pavelka & Tomáš Doležal
Pages: 183-192
Published online: 25 Nov 2019
AbstractforShort-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 161 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Effectiveness and safety of Ustekinumab for the treatment of Crohn’s disease in real-life experiences: a meta-analysis of observational studies
Fabio Salvatore Macaluso, Marcello Maida, Marco Ventimiglia, Mario Cottone & Ambrogio Orlando
Pages: 193-203
Published online: 26 Dec 2019
AbstractforEffectiveness and safety of Ustekinumab for the treatment of Crohn’s disease in real-life experiences: a meta-analysis of observational studies | Full Text | References | PDF (2.1 MB) | EPUB | Supplemental
  • 619 Views
  • 30 CrossRef citations
  • 0Altmetric
Article
Real-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease – A nationwide Hungarian cohort study
Renáta Bor, Anna Fábián, Mária Matuz, Zoltán Szepes, Klaudia Farkas, Pál Miheller, Tamás Szamosi, Áron Vincze, Mariann Rutka, Kata Szántó, Anita Bálint, Ferenc Nagy, Ágnes Milassin, Tibor Tóth, Ferenc Zsigmond, Judit Bajor, Katalin Müllner, Lilla Lakner, Mária Papp, Ágnes Salamon, Gábor Horváth, Krisztina Sarang, Eszter Schäfer, Patrícia Sarlós, Károly Palatka & Tamás Molnár
Pages: 205-213
Published online: 06 Dec 2019
AbstractforReal-life efficacy of vedolizumab on endoscopic healing in inflammatory bowel disease – A nationwide Hungarian cohort study | Full Text | References | PDF (2.1 MB) | EPUB
  • 2193 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access

Explore articles